BRIEF published on 11/20/2025 at 16:29, 9 months 21 days ago Vidac Pharma Holding Plc obtient l'autorisation de mener des essais cliniques Essai Clinique Vidac Pharma Conseils En Investissement Agence Européenne Des Médicaments Kératoses Actiniques
BRIEF published on 11/20/2025 at 16:12, 9 months 21 days ago Reply SpA: Quirin Privatbank Recommends "Buy" Rating Financial Results Revenue Growth AI Solutions Buy Recommendation Reply SpA
BRIEF published on 11/20/2025 at 16:12, 9 months 21 days ago Reply SpA : Quirin Privatbank recommande l'achat Résultats Financiers Recommandation D'achat Croissance Des Revenus Solutions D'IA Réponse SpA
BRIEF published on 11/20/2025 at 16:05, 9 months 21 days ago LEPAS Unveils “Leopard Aesthetics” in Automotive Design Interior Design LEPAS Leopard Aesthetics Automotive Design Nature Inspiration
BRIEF published on 11/20/2025 at 16:05, 9 months 21 days ago LEPAS dévoile une « esthétique léopard » dans le design automobile Design D'intérieur LEPAS Esthétique Léopard Conception Automobile Inspiration De La Nature
BRIEF published on 11/20/2025 at 16:05, 9 months 21 days ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Ordinary Shares Form 8.3 Zürcher Kantonalbank Takeover Disclosure Avadel Pharmaceuticals
BRIEF published on 11/20/2025 at 16:05, 9 months 21 days ago La Banque Cantonale de Zurich dévoile sa position dans Avadel Pharmaceuticals Actions Ordinaires Formulaire 8.3 Banque Cantonale De Zurich Avadel Pharmaceuticals Information Sur L'OPA
BRIEF published on 11/20/2025 at 16:00, 9 months 21 days ago SFC Energy AG: Analyst Maintains Buy Rating Despite Revised Target Growth Strategy Buy Recommendation Q3 Results SFC Energy AG Price Target
BRIEF published on 11/20/2025 at 16:00, 9 months 21 days ago SFC Energy AG : Un analyste maintient sa recommandation d’achat malgré un objectif révisé Stratégie De Croissance SFC Energy AG Recommandation D'achat Objectif De Cours Résultats Du Troisième Trimestre
BRIEF published on 11/20/2025 at 15:56, 9 months 21 days ago The Vanguard Group Discloses Position in Qualcomm Securities Form 8.3 Takeover Code Vanguard Group Qualcomm
Published on 09/11/2026 at 17:00, 22 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 22 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 1 hour 57 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 2 hours 22 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 2 hours 52 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 16:30, 51 minutes ago Belt and Road Summit in Hong Kong welcomes over 6,200 global leaders to explore new business opportunities
Published on 09/11/2026 at 16:00, 1 hour 21 minutes ago Deutsche Postbank Funding Trust III published semi-annual report
Published on 09/11/2026 at 16:00, 1 hour 21 minutes ago Form 8.3 - IPConcept (Luxemburg) S.A.: SONNTAG Premium
Published on 09/11/2026 at 15:29, 1 hour 52 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/11/2026 at 15:24, 1 hour 58 minutes ago Form 8.3 - The Vanguard Group, Inc.: Segro PLC
Published on 09/11/2026 at 07:00, 10 hours 22 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 10 hours 22 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 10 hours 22 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 10 hours 22 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 21 hours 52 minutes ago Availability of the 2026 Interim Financial Report
